MYCOPHENOLIC ACID

MYCOPHENOLIC ACID was reported 32735 times

MYCOPHENOLIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 23 0.7667
1 NEW ONSET DIABETES AFTER TRANSPLANTATION 52 0.3006
2 CENTRAL NERVOUS SYSTEM LUPUS 58 0.2601
3 MALACOPLAKIA 112 0.2445
4 URINOMA 33 0.2089
5 DELAYED GRAFT FUNCTION 134 0.1885
6 BACILLARY ANGIOMATOSIS 25 0.1838
7 DISSEMINATED NOCARDIOSIS 24 0.1727
8 PANCREAS TRANSPLANT REJECTION 34 0.1692
9 DONOR SPECIFIC ANTIBODY PRESENT 26 0.1688
10 HEART FAILURE WITH PRESERVED EJECTION FRACTION 49 0.1667
11 RHODOCOCCUS INFECTION 27 0.1627
12 COMPLICATIONS OF TRANSPLANTED KIDNEY 366 0.1612
13 CEREBRAL NOCARDIOSIS 37 0.1588
14 CHRONIC ALLOGRAFT NEPHROPATHY 122 0.1558
15 BODY MASS INDEX ABNORMAL 38 0.1557
16 KIDNEY TRANSPLANT REJECTION 716 0.1491
17 APOPTOSIS 44 0.1424
18 C3 GLOMERULOPATHY 28 0.1353
19 HUMAN EHRLICHIOSIS 28 0.1340
20 RENAL TRANSPLANT FAILURE 132 0.1336
21 RENAL CYST HAEMORRHAGE 30 0.1327
22 DISSEMINATED MUCORMYCOSIS 52 0.1320
23 TRICHODYSPLASIA SPINULOSA 50 0.1312
24 MONKEYPOX 36 0.1304
25 PULMONARY NOCARDIOSIS 105 0.1274
26 POLYOMAVIRUS VIRAEMIA 134 0.1262
27 AMAUROSIS FUGAX 134 0.1244
28 DISSEMINATED CRYPTOCOCCOSIS 94 0.1242
29 LYMPHOCELE 82 0.1235
30 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 285 0.1215
31 CRYPTOCOCCAL CUTANEOUS INFECTION 22 0.1209
32 WEST NILE VIRAL INFECTION 89 0.1187
33 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 27 0.1174
34 BLASTOMYCOSIS 54 0.1111
35 RENAL GRAFT INFECTION 25 0.1078
36 DISSEMINATED STRONGYLOIDIASIS 22 0.1005
37 TRANSPLANT DYSFUNCTION 177 0.0991
38 PHAEOHYPHOMYCOSIS 45 0.0939
39 TRANSPLANT REJECTION 745 0.0929
40 PARVOVIRUS B19 INFECTION 83 0.0927
41 RENAL TUBULAR ATROPHY 81 0.0918
42 HERPES SIMPLEX HEPATITIS 22 0.0917
43 CAT SCRATCH DISEASE 36 0.0896
44 CRYPTOCOCCOSIS 142 0.0871
45 ALTERNARIA INFECTION 32 0.0860
46 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 426 0.0836
47 HUMAN POLYOMAVIRUS INFECTION 42 0.0791
48 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 260 0.0786
49 BK VIRUS INFECTION 261 0.0773
50 SEROSITIS 42 0.0759
51 KIDNEY FIBROSIS 129 0.0743
52 CRYPTOSPORIDIOSIS INFECTION 39 0.0743
53 HEART TRANSPLANT REJECTION 77 0.0742
54 CYTOMEGALOVIRUS OESOPHAGITIS 27 0.0734
55 VASCULAR COMPRESSION 23 0.0728
56 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 22 0.0726
57 PULMONARY MUCORMYCOSIS 38 0.0720
58 CYSTITIS VIRAL 27 0.0705
59 TRANSPLANTATION COMPLICATION 29 0.0690
60 INFECTION REACTIVATION 78 0.0681
61 LUPUS NEPHRITIS 125 0.0668
62 PNEUMONIA CRYPTOCOCCAL 63 0.0667
63 UREAPLASMA INFECTION 27 0.0662
64 NOCARDIOSIS 165 0.0645
65 DOUBLE STRANDED DNA ANTIBODY POSITIVE 21 0.0644
66 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 103 0.0643
67 CYTOMEGALOVIRUS VIRAEMIA 286 0.0642
68 SCEDOSPORIUM INFECTION 45 0.0637
69 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 33 0.0630
70 LUNG TRANSPLANT REJECTION 41 0.0621
71 HEPATITIS E 96 0.0608
72 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 22 0.0604
73 HISTOPLASMOSIS DISSEMINATED 93 0.0586
74 INCISION SITE PAIN 68 0.0578
75 EPSTEIN-BARR VIRAEMIA 64 0.0577
76 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 69 0.0575
77 JC VIRUS INFECTION 91 0.0569
78 LIVER TRANSPLANT REJECTION 101 0.0562
79 TRANSPLANT FAILURE 131 0.0534
80 GRAFT LOSS 38 0.0524
81 GRAFT VERSUS HOST DISEASE IN LUNG 25 0.0523
82 CYTOMEGALOVIRUS INFECTION 831 0.0499
83 ANGIOSARCOMA 23 0.0499
84 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 29 0.0491
85 MENINGITIS CRYPTOCOCCAL 85 0.0486
86 STRONGYLOIDIASIS 78 0.0482
87 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 102 0.0479
88 RENAL ARTERY STENOSIS 66 0.0479
89 RED BLOOD CELLS URINE POSITIVE 46 0.0476
90 GRAFT VERSUS HOST DISEASE IN LIVER 34 0.0475
91 GLOMERULOSCLEROSIS 30 0.0475
92 CYTOMEGALOVIRUS COLITIS 109 0.0474
93 URETERIC STENOSIS 37 0.0462
94 GRAFT COMPLICATION 27 0.0460
95 VISCERAL LEISHMANIASIS 32 0.0443
96 GRAFT VERSUS HOST DISEASE IN SKIN 95 0.0431
97 BRAIN ABSCESS 107 0.0422
98 ALVEOLAR PROTEINOSIS 25 0.0422
99 MUCORMYCOSIS 109 0.0419
100 COMPLICATIONS OF TRANSPLANT SURGERY 21 0.0416
101 CEREBRAL TOXOPLASMOSIS 38 0.0407
102 INFECTION IN AN IMMUNOCOMPROMISED HOST 29 0.0404
103 RENAL TUBULAR INJURY 48 0.0395
104 ENTEROCOCCAL INFECTION 185 0.0382
105 VARICELLA ZOSTER VIRUS INFECTION 78 0.0376
106 HUMAN HERPESVIRUS 8 INFECTION 22 0.0361
107 RENAL TRANSPLANT 130 0.0360
108 VIRAEMIA 49 0.0354
109 ENCEPHALITIS VIRAL 42 0.0345
110 CEREBRAL ASPERGILLOSIS 21 0.0341
111 HISTOPLASMOSIS 60 0.0339
112 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 27 0.0332
113 PNEUMONIA CYTOMEGALOVIRAL 64 0.0329
114 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 46 0.0326
115 ANOGENITAL WARTS 29 0.0325
116 INTERVERTEBRAL DISC SPACE NARROWING 26 0.0323
117 KLEBSIELLA INFECTION 163 0.0322
118 EPSTEIN-BARR VIRUS INFECTION 198 0.0317
119 URINARY TRACT DISORDER 142 0.0315
120 ENTEROBACTER INFECTION 52 0.0309
121 HUMAN HERPESVIRUS 6 INFECTION 58 0.0307
122 CENTRAL NERVOUS SYSTEM LYMPHOMA 42 0.0305
123 ASPERGILLUS INFECTION 200 0.0304
124 SUPERINFECTION BACTERIAL 24 0.0303
125 ACINETOBACTER INFECTION 33 0.0301
126 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 53 0.0300
127 CAROTID ARTERIOSCLEROSIS 30 0.0291
128 BRONCHOPULMONARY ASPERGILLOSIS 225 0.0290
129 THROMBOTIC MICROANGIOPATHY 281 0.0288
130 AORTIC DILATATION 32 0.0288
131 GASTROENTERITIS NOROVIRUS 38 0.0286
132 ADENOVIRUS INFECTION 83 0.0286
133 IGA NEPHROPATHY 47 0.0283
134 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 37 0.0281
135 PNEUMONIA PSEUDOMONAL 43 0.0280
136 PAPILLOMA VIRAL INFECTION 46 0.0279
137 ENTEROVIRUS INFECTION 24 0.0278
138 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0270
139 TRANSITIONAL CELL CARCINOMA 35 0.0270
140 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 202 0.0269
141 DISSEMINATED TUBERCULOSIS 69 0.0269
142 HYPERPARATHYROIDISM SECONDARY 67 0.0267
143 NOROVIRUS INFECTION 38 0.0263
144 KLEBSIELLA BACTERAEMIA 25 0.0263
145 DRUG LEVEL FLUCTUATING 23 0.0259
146 PSEUDOMONAL BACTERAEMIA 22 0.0258
147 RECTAL PROLAPSE 31 0.0257
148 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
149 OBLITERATIVE BRONCHIOLITIS 33 0.0251
150 SECONDARY IMMUNODEFICIENCY 30 0.0247
151 PYELONEPHRITIS ACUTE 48 0.0245
152 TOXOPLASMOSIS 26 0.0241
153 BUTTERFLY RASH 24 0.0237
154 APLASIA PURE RED CELL 81 0.0235
155 LISTERIOSIS 26 0.0235
156 CYTOMEGALOVIRUS INFECTION REACTIVATION 103 0.0233
157 KLEBSIELLA SEPSIS 26 0.0231
158 VACCINATION FAILURE 38 0.0228
159 PNEUMONIA KLEBSIELLA 41 0.0223
160 PSEUDOMONAS INFECTION 190 0.0221
161 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 60 0.0217
162 SYSTEMIC MYCOSIS 25 0.0214
163 CHRONIC GRAFT VERSUS HOST DISEASE 77 0.0213
164 PNEUMOCYSTIS JIROVECII PNEUMONIA 214 0.0213
165 ESCHERICHIA INFECTION 175 0.0213
166 GLOMERULONEPHRITIS 52 0.0212
167 PROTEIN URINE PRESENT 105 0.0210
168 ESCHERICHIA URINARY TRACT INFECTION 88 0.0207
169 STENOTROPHOMONAS INFECTION 28 0.0206
170 HAEMORRHAGIC STROKE 160 0.0205
171 HAEMOLYTIC URAEMIC SYNDROME 47 0.0203
172 ACUTE GRAFT VERSUS HOST DISEASE 92 0.0201
173 CYTOMEGALOVIRUS TEST POSITIVE 35 0.0196
174 RENAL TUBULAR NECROSIS 191 0.0195
175 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 184 0.0193
176 GINGIVAL HYPERTROPHY 29 0.0191
177 CYSTITIS HAEMORRHAGIC 77 0.0191
178 NEPHROPATHY TOXIC 213 0.0190
179 MYCOBACTERIAL INFECTION 32 0.0186
180 HYPERPARATHYROIDISM 38 0.0184
181 ESCHERICHIA BACTERAEMIA 43 0.0183
182 DIFFUSE ALVEOLAR DAMAGE 21 0.0183
183 PNEUMONIA FUNGAL 72 0.0182
184 HYDRONEPHROSIS 136 0.0181
185 ACTINIC KERATOSIS 47 0.0181
186 SQUAMOUS CELL CARCINOMA OF SKIN 109 0.0180
187 PROTEINURIA 342 0.0180
188 CYTOMEGALOVIRUS CHORIORETINITIS 35 0.0179
189 LARGE INTESTINE INFECTION 22 0.0179
190 OESOPHAGEAL ULCER 67 0.0174
191 B-CELL LYMPHOMA 59 0.0174
192 DISTRIBUTIVE SHOCK 39 0.0172
193 URINARY TRACT INFECTION BACTERIAL 43 0.0170
194 PYELONEPHRITIS 147 0.0169
195 CALCIPHYLAXIS 31 0.0169
196 PNEUMONIA LEGIONELLA 27 0.0169
197 HYPOGAMMAGLOBULINAEMIA 109 0.0166
198 INFECTIOUS PLEURAL EFFUSION 25 0.0164
199 GRAFT VERSUS HOST DISEASE 116 0.0161
200 HAEMATOLOGICAL INFECTION 38 0.0155
201 ESCHERICHIA SEPSIS 45 0.0155
202 COVID-19 PNEUMONIA 179 0.0151
203 SYSTEMIC INFECTION 25 0.0151
204 GENERALISED OEDEMA 185 0.0149
205 HYPOALBUMINAEMIA 115 0.0148
206 NEPHROGENIC ANAEMIA 68 0.0147
207 STEROID DIABETES 22 0.0147
208 PNEUMOPERITONEUM 27 0.0146
209 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 72 0.0144
210 UROSEPSIS 133 0.0144
211 SALMONELLOSIS 24 0.0142
212 DRUG LEVEL INCREASED 235 0.0142
213 DIFFUSE LARGE B-CELL LYMPHOMA 109 0.0141
214 CONCOMITANT DISEASE PROGRESSION 27 0.0138
215 BACTERIAL SEPSIS 45 0.0138
216 BLOOD CREATININE INCREASED 892 0.0136
217 HEPATOSPLENOMEGALY 35 0.0136
218 BLOOD CREATININE ABNORMAL 47 0.0136
219 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111 0.0134
220 PNEUMOMEDIASTINUM 24 0.0133
221 OCULAR DISCOMFORT 148 0.0132
222 CUSHINGOID 42 0.0131
223 ELECTROLYTE IMBALANCE 152 0.0131
224 HERPES SIMPLEX 85 0.0131
225 MULTIPLE ORGAN DYSFUNCTION SYNDROME 369 0.0130
226 EMPYEMA 25 0.0126
227 OESOPHAGEAL STENOSIS 35 0.0123
228 OESOPHAGEAL CANDIDIASIS 49 0.0123
229 NEPHROTIC SYNDROME 84 0.0122
230 LEUKOPENIA 609 0.0122
231 ACUTE RESPIRATORY DISTRESS SYNDROME 215 0.0121
232 MEAN CELL VOLUME INCREASED 31 0.0121
233 RHINOVIRUS INFECTION 47 0.0121
234 AORTIC ARTERIOSCLEROSIS 31 0.0120
235 LARGE INTESTINAL ULCER 32 0.0118
236 END STAGE RENAL DISEASE 212 0.0116
237 DRUG LEVEL ABOVE THERAPEUTIC 52 0.0113
238 HYPERVOLAEMIA 55 0.0111
239 BLOOD UREA INCREASED 186 0.0111
240 LUNG CONSOLIDATION 31 0.0111
241 NEUTROPHIL COUNT INCREASED 112 0.0109
242 SEPTIC SHOCK 470 0.0108
243 DUODENITIS 33 0.0107
244 SCLERODERMA 39 0.0107
245 RENAL TUBULAR ACIDOSIS 23 0.0105
246 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
247 GRANULOMA 36 0.0104
248 BACTERAEMIA 123 0.0104
249 PNEUMONIA VIRAL 33 0.0103
250 ORGANISING PNEUMONIA 51 0.0103
251 ENCEPHALITIS 71 0.0103
252 DYSLIPIDAEMIA 51 0.0100
253 AZOTAEMIA 40 0.0100
254 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
255 HEPATIC FIBROSIS 34 0.0099
256 DERMATOMYOSITIS 25 0.0099
257 HYPERURICAEMIA 40 0.0097
258 LYMPHOPENIA 137 0.0097
259 MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.0097
260 LIVER TRANSPLANT 35 0.0096
261 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
262 SYSTEMIC CANDIDA 24 0.0096
263 PNEUMATOSIS INTESTINALIS 27 0.0095
264 ACUTE RESPIRATORY FAILURE 182 0.0095
265 PATHOGEN RESISTANCE 86 0.0094
266 BILIRUBIN CONJUGATED INCREASED 22 0.0094
267 NEPHROPATHY 87 0.0093
268 HAEMATURIA 316 0.0092
269 GLOMERULAR FILTRATION RATE DECREASED 113 0.0092
270 CANDIDA INFECTION 155 0.0092
271 ENDOCARDITIS 47 0.0092
272 URINE OUTPUT DECREASED 80 0.0091
273 CLOSTRIDIUM DIFFICILE COLITIS 97 0.0091
274 DIVERTICULUM INTESTINAL 40 0.0091
275 BENIGN PROSTATIC HYPERPLASIA 47 0.0091
276 BRAIN HERNIATION 27 0.0090
277 OLIGURIA 56 0.0090
278 RENAL IMPAIRMENT 752 0.0089
279 SQUAMOUS CELL CARCINOMA 84 0.0089
280 LYMPHOCYTE COUNT DECREASED 156 0.0088
281 ACUTE KIDNEY INJURY 1344 0.0088
282 LUNG TRANSPLANT 31 0.0087
283 HEAD DISCOMFORT 155 0.0087
284 POSTOPERATIVE WOUND INFECTION 59 0.0087
285 VENOOCCLUSIVE LIVER DISEASE 43 0.0087
286 MYASTHENIA GRAVIS 70 0.0087
287 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 33 0.0086
288 WOUND DEHISCENCE 29 0.0086
289 LYMPHOPROLIFERATIVE DISORDER 25 0.0085
290 BLOOD IMMUNOGLOBULIN G DECREASED 21 0.0085
291 URINE ANALYSIS ABNORMAL 25 0.0084
292 PHOTOPHOBIA 155 0.0082
293 ABDOMINAL INFECTION 21 0.0082
294 BONE EROSION 29 0.0082
295 ASCITES 241 0.0082
296 HEPATITIS B REACTIVATION 26 0.0082
297 FIBROSIS 25 0.0081
298 SPINAL STENOSIS 33 0.0080
299 TUBULOINTERSTITIAL NEPHRITIS 149 0.0079
300 CHOLANGITIS 49 0.0079
301 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
302 BLOOD ALBUMIN DECREASED 62 0.0078
303 NEPHRITIS 26 0.0078
304 HISTIOCYTOSIS HAEMATOPHAGIC 23 0.0077
305 BRONCHIECTASIS 52 0.0077
306 BLOOD CREATINE INCREASED 34 0.0077
307 THROMBOTIC THROMBOCYTOPENIC PURPURA 27 0.0077
308 ALTERED STATE OF CONSCIOUSNESS 166 0.0077
309 NORMOCHROMIC NORMOCYTIC ANAEMIA 23 0.0076
310 NEPHROGENIC SYSTEMIC FIBROSIS 23 0.0076
311 PRESYNCOPE 182 0.0075
312 HEPATIC NECROSIS 28 0.0074
313 FUNGAL SKIN INFECTION 30 0.0074
314 LIVER ABSCESS 24 0.0074
315 NECROTISING FASCIITIS 26 0.0074
316 CARDIAC FAILURE ACUTE 49 0.0073
317 AUTOIMMUNE HAEMOLYTIC ANAEMIA 25 0.0073
318 URINE ABNORMALITY 33 0.0073
319 PROSTATITIS 22 0.0072
320 HYPERKALAEMIA 252 0.0072
321 ARTERIOSCLEROSIS 67 0.0071
322 BLOOD URIC ACID INCREASED 41 0.0071
323 HAEMODYNAMIC INSTABILITY 54 0.0071
324 HYPOPHOSPHATAEMIA 52 0.0070
325 GASTROENTERITIS 102 0.0070
326 METABOLIC ACIDOSIS 221 0.0069
327 INTESTINAL ISCHAEMIA 38 0.0069
328 RESPIRATORY FAILURE 501 0.0069
329 BASAL CELL CARCINOMA 107 0.0069
330 HYPOVOLAEMIA 40 0.0068
331 SYSTEMIC LUPUS ERYTHEMATOSUS 242 0.0068
332 HAEMOLYTIC ANAEMIA 61 0.0068
333 IMMUNOSUPPRESSION 60 0.0068
334 MYOSITIS 61 0.0068
335 AGRANULOCYTOSIS 126 0.0068
336 RENAL FAILURE CHRONIC 52 0.0068
337 SKIN NECROSIS 35 0.0067
338 ENCEPHALOPATHY 165 0.0067
339 HAEMATEMESIS 169 0.0067
340 FUNCTIONAL GASTROINTESTINAL DISORDER 23 0.0066
341 BACTERIAL INFECTION 124 0.0066
342 PAPILLOEDEMA 30 0.0066
343 INTRACRANIAL PRESSURE INCREASED 37 0.0066
344 ANURIA 57 0.0066
345 SEPSIS 738 0.0066
346 HERPES VIRUS INFECTION 38 0.0066
347 DIPLOPIA 171 0.0066
348 AORTIC VALVE INCOMPETENCE 28 0.0066
349 ARTHRITIS BACTERIAL 27 0.0066
350 ENTERITIS 42 0.0066
351 ABDOMINAL ABSCESS 29 0.0066
352 SKIN PAPILLOMA 26 0.0065
353 BLINDNESS 259 0.0063
354 HYPERCALCAEMIA 78 0.0063
355 DRUG LEVEL DECREASED 64 0.0063
356 PANCYTOPENIA 346 0.0062
357 SHOCK HAEMORRHAGIC 50 0.0061
358 PNEUMONIA BACTERIAL 56 0.0061
359 RENAL FUNCTION TEST ABNORMAL 28 0.0060
360 COVID-19 1057 0.0060
361 ATELECTASIS 58 0.0060
362 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 30 0.0059
363 LEUKOCYTOSIS 107 0.0059
364 CORONAVIRUS INFECTION 39 0.0059
365 ACIDOSIS 45 0.0059
366 NEUROTOXICITY 102 0.0058
367 HEPATITIS CHOLESTATIC 35 0.0058
368 LUNG INFECTION 90 0.0058
369 PULMONARY MASS 86 0.0058
370 APLASTIC ANAEMIA 30 0.0057
371 DRUG INTERACTION 905 0.0057
372 ACUTE PULMONARY OEDEMA 32 0.0057
373 RENAL CYST 45 0.0057
374 LARGE INTESTINE POLYP 39 0.0056
375 POLYURIA 46 0.0056
376 C-REACTIVE PROTEIN INCREASED 204 0.0056
377 WOUND INFECTION 61 0.0056
378 LARGE INTESTINE PERFORATION 38 0.0055
379 HYPERTRIGLYCERIDAEMIA 32 0.0055
380 MOUTH ULCERATION 115 0.0055
381 MYOPATHY 47 0.0054
382 HYPOVOLAEMIC SHOCK 26 0.0054
383 GUILLAIN-BARRE SYNDROME 26 0.0054
384 CYTOPENIA 65 0.0053
385 GOUT 95 0.0053
386 STAPHYLOCOCCAL SEPSIS 26 0.0053
387 PULSELESS ELECTRICAL ACTIVITY 22 0.0053
388 HYPOMAGNESAEMIA 73 0.0052
389 RED BLOOD CELL SEDIMENTATION RATE INCREASED 58 0.0052
390 MENINGITIS 35 0.0052
391 BLOOD POTASSIUM INCREASED 85 0.0052
392 HEPATIC ENZYME ABNORMAL 26 0.0052
393 METASTASES TO LYMPH NODES 35 0.0052
394 DRUG RESISTANCE 133 0.0052
395 HYPERTRANSAMINASAEMIA 36 0.0052
396 COMA 246 0.0052
397 PURULENT DISCHARGE 22 0.0051
398 HEPATOCELLULAR CARCINOMA 39 0.0051
399 DISEASE RECURRENCE 243 0.0051
400 FOOD POISONING 27 0.0050
401 PEMPHIGOID 38 0.0050
402 ODYNOPHAGIA 30 0.0050
403 PULMONARY FUNCTION TEST DECREASED 22 0.0050
404 HYPERLIPIDAEMIA 60 0.0050
405 RESPIRATORY DISTRESS 138 0.0050
406 C-REACTIVE PROTEIN ABNORMAL 32 0.0050
407 IRON DEFICIENCY ANAEMIA 46 0.0050
408 LUNG INFILTRATION 44 0.0050
409 VITAMIN D DECREASED 42 0.0049
410 URINARY TRACT INFECTION 829 0.0049
411 HEPATIC ENCEPHALOPATHY 45 0.0048
412 DUODENAL ULCER 34 0.0048
413 HAEMORRHOIDS 94 0.0048
414 FAILURE TO THRIVE 25 0.0048
415 HYPERAMMONAEMIA 24 0.0048
416 HYPERGLYCAEMIA 173 0.0047
417 EXERCISE TOLERANCE DECREASED 27 0.0047
418 RENAL DISORDER 218 0.0047
419 ENTEROCOLITIS 27 0.0047
420 NECROSIS 26 0.0047
421 HAEMOGLOBIN ABNORMAL 30 0.0047
422 GANGRENE 28 0.0046
423 BLOOD MAGNESIUM DECREASED 40 0.0046
424 PRE-ECLAMPSIA 22 0.0046
425 ABDOMINAL HERNIA 21 0.0046
426 PULMONARY FIBROSIS 88 0.0046
427 OSTEOMYELITIS 83 0.0046
428 OESOPHAGITIS 50 0.0046
429 CLOSTRIDIUM DIFFICILE INFECTION 99 0.0045
430 HAEMOLYSIS 35 0.0045
431 DIABETES MELLITUS 345 0.0045
432 COLITIS 171 0.0045
433 GASTROINTESTINAL DISORDER 404 0.0045
434 RENAL FAILURE 598 0.0045
435 CHRONIC KIDNEY DISEASE 342 0.0045
436 FUNGAL INFECTION 150 0.0045
437 CHOLESTASIS 86 0.0045
438 HEPATITIS C 54 0.0045
439 BREATH SOUNDS ABNORMAL 22 0.0045
440 SWELLING OF EYELID 28 0.0045
441 SHOCK 102 0.0044
442 KIDNEY INFECTION 87 0.0044
443 STAPHYLOCOCCAL INFECTION 146 0.0044
444 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 242 0.0044
445 CORONARY ARTERY STENOSIS 22 0.0044
446 DISSEMINATED INTRAVASCULAR COAGULATION 61 0.0043
447 LOWER GASTROINTESTINAL HAEMORRHAGE 32 0.0043
448 HAEMOGLOBIN DECREASED 444 0.0043
449 DIALYSIS 61 0.0043
450 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38 0.0043
451 VIRAL INFECTION 143 0.0043
452 CARDIO-RESPIRATORY ARREST 178 0.0043
453 INTERSTITIAL LUNG DISEASE 205 0.0042
454 VASCULITIS 49 0.0042
455 INFLAMMATORY BOWEL DISEASE 41 0.0042
456 SKIN LESION 114 0.0042
457 HEPATITIS B 25 0.0041
458 NEUTROPENIA 559 0.0041
459 SPINAL OSTEOARTHRITIS 36 0.0041
460 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 42 0.0041
461 HYPOXIA 142 0.0040
462 PYREXIA 1362 0.0039
463 ANGIOPATHY 22 0.0039
464 PRODUCT USE IN UNAPPROVED INDICATION 972 0.0039
465 PNEUMOTHORAX 62 0.0039
466 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
467 MALIGNANT MELANOMA 52 0.0039
468 PLEURISY 23 0.0039
469 THERAPY CHANGE 38 0.0039
470 DIVERTICULITIS 107 0.0039
471 ANAEMIA 735 0.0038
472 SKIN INFECTION 43 0.0038
473 ABNORMAL LOSS OF WEIGHT 26 0.0038
474 MATERNAL EXPOSURE BEFORE PREGNANCY 26 0.0038
475 BRAIN OEDEMA 48 0.0038
476 PLEURAL EFFUSION 231 0.0038
477 PANCREATITIS ACUTE 85 0.0038
478 MULTI-ORGAN FAILURE 65 0.0038
479 MALNUTRITION 42 0.0038
480 SMALL INTESTINAL OBSTRUCTION 46 0.0037
481 FLUID OVERLOAD 54 0.0037
482 PEMPHIGUS 46 0.0037
483 PERICARDIAL EFFUSION 85 0.0037
484 ENDOPHTHALMITIS 22 0.0037
485 BLOOD LACTATE DEHYDROGENASE INCREASED 58 0.0037
486 ACUTE HEPATIC FAILURE 50 0.0037
487 TACHYCARDIA 325 0.0037
488 HEPATIC STEATOSIS 68 0.0036
489 BONE MARROW FAILURE 74 0.0036
490 FLANK PAIN 34 0.0036
491 ISCHAEMIC STROKE 64 0.0036
492 EYE PAIN 202 0.0036
493 PULMONARY HYPERTENSION 74 0.0035
494 METASTASES TO LUNG 41 0.0035
495 ILEUS 44 0.0035
496 THERAPY NON-RESPONDER 159 0.0035
497 GASTRITIS 93 0.0035
498 TACHYPNOEA 48 0.0035
499 PNEUMONITIS 96 0.0035
500 HAEMATOMA 91 0.0035
501 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
502 MENTAL STATUS CHANGES 96 0.0035
503 FAECES SOFT 25 0.0034
504 INFECTION 496 0.0034
505 BLOOD URINE PRESENT 65 0.0034
506 TINNITUS 157 0.0034
507 BLOOD PRESSURE FLUCTUATION 82 0.0034
508 THROMBOCYTOPENIA 380 0.0034
509 PREMATURE DELIVERY 54 0.0034
510 OFF LABEL USE 2957 0.0034
511 BLOOD DISORDER 27 0.0034
512 DYSURIA 124 0.0034
513 GASTRIC ULCER 64 0.0034
514 HERPES ZOSTER 193 0.0034
515 CHILLS 391 0.0033
516 RENAL FAILURE ACUTE 141 0.0033
517 PERITONITIS 68 0.0033
518 TOXICITY TO VARIOUS AGENTS 553 0.0033
519 MITRAL VALVE INCOMPETENCE 37 0.0033
520 MUCOSAL INFLAMMATION 85 0.0032
521 DIVERTICULUM 23 0.0032
522 PRODUCT PRESCRIBING ERROR 77 0.0032
523 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
524 RESPIRATORY TRACT INFECTION 84 0.0032
525 UPPER RESPIRATORY TRACT INFECTION 149 0.0032
526 RED BLOOD CELL COUNT DECREASED 92 0.0032
527 LUNG DISORDER 157 0.0032
528 GENERALISED TONIC-CLONIC SEIZURE 53 0.0032
529 REBOUND EFFECT 36 0.0032
530 VITAMIN D DEFICIENCY 31 0.0032
531 DIARRHOEA 2043 0.0032
532 TRANSAMINASES INCREASED 70 0.0031
533 HYPERTHERMIA 24 0.0031
534 MYOCARDITIS 36 0.0031
535 ABSCESS 50 0.0031
536 HYPERTENSION 663 0.0031
537 HEPATIC FAILURE 94 0.0031
538 ORAL CANDIDIASIS 41 0.0031
539 SKIN CANCER 67 0.0031
540 DYSPNOEA EXERTIONAL 117 0.0031
541 INFUSION SITE PAIN 40 0.0031
542 DIARRHOEA HAEMORRHAGIC 29 0.0031
543 PERICARDITIS 52 0.0031
544 SKIN ULCER 80 0.0031
545 APHTHOUS ULCER 24 0.0031
546 PNEUMONIA 997 0.0031
547 HEMIPARESIS 52 0.0031
548 DRUG INTOLERANCE 296 0.0031
549 HEPATOTOXICITY 68 0.0031
550 OSTEOPENIA 46 0.0030
551 RENAL PAIN 32 0.0030
552 HYPERCHOLESTEROLAEMIA 29 0.0030
553 COAGULOPATHY 50 0.0030
554 PRODUCTIVE COUGH 143 0.0030
555 TREATMENT FAILURE 248 0.0030
556 DEVICE RELATED INFECTION 46 0.0030
557 AUTOIMMUNE DISORDER 29 0.0030
558 MUSCLE DISORDER 24 0.0030
559 PNEUMONIA ASPIRATION 74 0.0030
560 IMMUNE SYSTEM DISORDER 39 0.0030
561 LIVER FUNCTION TEST ABNORMAL 85 0.0029
562 QUALITY OF LIFE DECREASED 39 0.0029
563 ABDOMINAL PAIN 674 0.0029
564 THERAPY PARTIAL RESPONDER 45 0.0029
565 PERITONITIS BACTERIAL 29 0.0029
566 CARDIOGENIC SHOCK 41 0.0029
567 HYPOCALCAEMIA 54 0.0029
568 LIVER INJURY 70 0.0028
569 OEDEMA PERIPHERAL 347 0.0028
570 ULCER 45 0.0028
571 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0028
572 HYPOKALAEMIA 130 0.0028
573 OSTEOPOROSIS 115 0.0028
574 APPENDICITIS 26 0.0028
575 BLOOD PRESSURE INCREASED 424 0.0028
576 BLOOD TRIGLYCERIDES INCREASED 49 0.0028
577 SYNOVITIS 50 0.0028
578 INFLAMMATION 143 0.0028
579 INTESTINAL PERFORATION 31 0.0028
580 BLOOD SODIUM DECREASED 52 0.0028
581 FISTULA 31 0.0028
582 BLOOD CALCIUM DECREASED 31 0.0028
583 TREATMENT NONCOMPLIANCE 150 0.0027
584 HAEMODIALYSIS 23 0.0027
585 COUGH 768 0.0027
586 SENSORY LOSS 22 0.0027
587 DEHYDRATION 364 0.0027
588 HAEMATOCRIT DECREASED 54 0.0027
589 HYPERBILIRUBINAEMIA 28 0.0027
590 PULMONARY OEDEMA 121 0.0027
591 SCIATICA 43 0.0027
592 BLOOD IRON DECREASED 32 0.0027
593 OEDEMA 145 0.0027
594 PHARYNGITIS 33 0.0027
595 ACUTE CORONARY SYNDROME 22 0.0027
596 HYPOTHYROIDISM 84 0.0026
597 IMPAIRED HEALING 86 0.0026
598 HYPOTONIA 26 0.0026
599 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 76 0.0026
600 BLOOD BILIRUBIN INCREASED 70 0.0026
601 FACIAL PARALYSIS 22 0.0026
602 GASTROINTESTINAL INFECTION 23 0.0026
603 DRUG-INDUCED LIVER INJURY 80 0.0025
604 GASTROENTERITIS VIRAL 46 0.0025
605 MATERNAL EXPOSURE DURING PREGNANCY 227 0.0025
606 HAEMATOTOXICITY 24 0.0025
607 CHOLECYSTITIS 30 0.0025
608 BLOOD CALCIUM INCREASED 22 0.0025
609 CARDIAC ARREST 207 0.0025
610 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
611 HYPONATRAEMIA 141 0.0025
612 FLUID RETENTION 127 0.0025
613 CEREBRAL INFARCTION 61 0.0025
614 TENDERNESS 26 0.0025
615 PURPURA 22 0.0025
616 IMMUNODEFICIENCY 37 0.0025
617 FEBRILE NEUTROPENIA 163 0.0025
618 HEPATIC CIRRHOSIS 46 0.0024
619 GAMMA-GLUTAMYLTRANSFERASE INCREASED 54 0.0024
620 UVEITIS 33 0.0024
621 ABDOMINAL PAIN LOWER 61 0.0024
622 HIDRADENITIS 22 0.0024
623 HAEMOPTYSIS 67 0.0024
624 SECRETION DISCHARGE 30 0.0024
625 METASTASES TO LIVER 42 0.0024
626 HERNIA 46 0.0024
627 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
628 APHONIA 33 0.0024
629 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
630 ORAL HERPES 46 0.0024
631 THERAPY INTERRUPTED 168 0.0023
632 SARS-COV-2 TEST POSITIVE 31 0.0023
633 CONDITION AGGRAVATED 711 0.0023
634 CELLULITIS 117 0.0023
635 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
636 CATARACT 138 0.0023
637 LACTIC ACIDOSIS 75 0.0023
638 SPLENOMEGALY 27 0.0023
639 GASTROOESOPHAGEAL REFLUX DISEASE 184 0.0023
640 ASPIRATION 25 0.0023
641 INTERNAL HAEMORRHAGE 26 0.0023
642 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
643 SYNCOPE 227 0.0023
644 CENTRAL NERVOUS SYSTEM LESION 31 0.0023
645 INFLUENZA 249 0.0022
646 GLAUCOMA 43 0.0022
647 LYMPHADENOPATHY 79 0.0022
648 ADRENAL INSUFFICIENCY 27 0.0022
649 ABORTION SPONTANEOUS 89 0.0022
650 MYALGIA 377 0.0022
651 URINARY RETENTION 73 0.0022
652 OXYGEN SATURATION DECREASED 122 0.0022
653 ATRIAL FIBRILLATION 210 0.0022
654 RENAL INJURY 64 0.0022
655 POST PROCEDURAL COMPLICATION 41 0.0021
656 DISEASE PROGRESSION 252 0.0021
657 VOMITING 1001 0.0021
658 HYPOPHAGIA 54 0.0021
659 PRODUCT PRESCRIBING ISSUE 46 0.0021
660 HEPATITIS 54 0.0021
661 PARALYSIS 30 0.0021
662 ABDOMINAL PAIN UPPER 431 0.0021
663 TREMOR 345 0.0021
664 LABORATORY TEST ABNORMAL 61 0.0021
665 DECREASED APPETITE 479 0.0021
666 ALANINE AMINOTRANSFERASE INCREASED 126 0.0021
667 HEPATOCELLULAR INJURY 29 0.0020
668 CYTOKINE RELEASE SYNDROME 41 0.0020
669 DIABETIC KETOACIDOSIS 49 0.0020
670 HEPATIC CYTOLYSIS 26 0.0020
671 ABDOMINAL DISCOMFORT 340 0.0020
672 LOCALISED INFECTION 49 0.0020
673 INTENTIONAL PRODUCT USE ISSUE 175 0.0020
674 WHITE BLOOD CELL COUNT DECREASED 216 0.0020
675 DELIRIUM 69 0.0020
676 RESTLESS LEGS SYNDROME 36 0.0020
677 WEIGHT DECREASED 551 0.0020
678 HEPATIC ENZYME INCREASED 134 0.0020
679 BLOOD GLUCOSE ABNORMAL 36 0.0019
680 CYSTITIS 62 0.0019
681 ASTHENIA 726 0.0019
682 HIATUS HERNIA 25 0.0019
683 GENERAL PHYSICAL HEALTH DETERIORATION 223 0.0019
684 BLOOD TEST ABNORMAL 27 0.0019
685 WRIST FRACTURE 23 0.0019
686 MYELOSUPPRESSION 69 0.0019
687 VISION BLURRED 263 0.0019
688 BLINDNESS UNILATERAL 27 0.0019
689 NEOPLASM 22 0.0019
690 RESPIRATORY DISORDER 57 0.0019
691 JAUNDICE 51 0.0019
692 EOSINOPHILIA 33 0.0019
693 LYMPHOMA 29 0.0019
694 PANCREATITIS 99 0.0019
695 LIVER DISORDER 83 0.0019
696 ABDOMINAL DISTENSION 195 0.0019
697 HOSPITALISATION 286 0.0019
698 OSTEONECROSIS 61 0.0019
699 BLOOD CHOLESTEROL INCREASED 86 0.0018
700 THROMBOSIS 148 0.0018
701 PROCEDURAL PAIN 51 0.0018
702 ORTHOSTATIC HYPOTENSION 32 0.0018
703 CARDIAC FAILURE 147 0.0018
704 HYPOTENSION 367 0.0018
705 LOWER LIMB FRACTURE 35 0.0018
706 DEEP VEIN THROMBOSIS 118 0.0018
707 NIGHT SWEATS 58 0.0018
708 GASTROINTESTINAL HAEMORRHAGE 150 0.0018
709 JOINT RANGE OF MOTION DECREASED 24 0.0018
710 TENDON RUPTURE 22 0.0018
711 ATAXIA 21 0.0018
712 HEPATIC FUNCTION ABNORMAL 66 0.0018
713 DERMATITIS 37 0.0018
714 BODY TEMPERATURE INCREASED 36 0.0018
715 IMPAIRED GASTRIC EMPTYING 24 0.0018
716 LIMB DISCOMFORT 54 0.0017
717 MALAISE 758 0.0017
718 HYPERTHYROIDISM 25 0.0017
719 INTESTINAL OBSTRUCTION 65 0.0017
720 PERIPHERAL SWELLING 264 0.0017
721 DYSPNOEA 965 0.0017
722 INSURANCE ISSUE 26 0.0017
723 SOMNOLENCE 340 0.0017
724 FOOT FRACTURE 32 0.0017
725 PULMONARY EMBOLISM 160 0.0017
726 DEATH 1450 0.0017
727 BRADYCARDIA 89 0.0017
728 SURGERY 98 0.0017
729 MYELODYSPLASTIC SYNDROME 24 0.0017
730 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
731 APHASIA 50 0.0017
732 PRESCRIBED UNDERDOSE 33 0.0017
733 HYPOACUSIS 70 0.0016
734 SEASONAL ALLERGY 23 0.0016
735 ILLNESS 167 0.0016
736 LIMB INJURY 44 0.0016
737 SKIN DISORDER 54 0.0016
738 ANKLE FRACTURE 25 0.0016
739 PLATELET COUNT DECREASED 172 0.0016
740 PRODUCT USE ISSUE 303 0.0016
741 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
742 UPPER LIMB FRACTURE 32 0.0016
743 BRAIN FOG 25 0.0016
744 PSYCHOTIC DISORDER 47 0.0016
745 SINUSITIS 163 0.0016
746 METASTASES TO BONE 26 0.0016
747 LOWER RESPIRATORY TRACT INFECTION 72 0.0016
748 SWELLING 148 0.0016
749 INTENTIONAL DOSE OMISSION 45 0.0016
750 HEADACHE 989 0.0016
751 NERVOUS SYSTEM DISORDER 49 0.0016
752 DEAFNESS 41 0.0016
753 NAUSEA 1239 0.0016
754 HALLUCINATION, VISUAL 33 0.0016
755 JOINT STIFFNESS 41 0.0016
756 DYSPHAGIA 148 0.0016
757 EYE DISORDER 51 0.0015
758 SINUS TACHYCARDIA 22 0.0015
759 MUSCULAR WEAKNESS 176 0.0015
760 RHINORRHOEA 100 0.0015
761 MELAENA 34 0.0015
762 TYPE 2 DIABETES MELLITUS 52 0.0015
763 NASOPHARYNGITIS 284 0.0015
764 LIVER FUNCTION TEST INCREASED 33 0.0015
765 CEREBRAL HAEMORRHAGE 55 0.0015
766 ANGINA PECTORIS 44 0.0015
767 RASH MACULO-PAPULAR 34 0.0015
768 PREMATURE BABY 46 0.0015
769 BRONCHITIS 113 0.0015
770 OROPHARYNGEAL PAIN 141 0.0015
771 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
772 CORONARY ARTERY DISEASE 46 0.0015
773 OBESITY 24 0.0015
774 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
775 EPILEPSY 46 0.0015
776 HIP ARTHROPLASTY 23 0.0015
777 BLOOD POTASSIUM DECREASED 45 0.0015
778 CHOLELITHIASIS 49 0.0015
779 SWELLING FACE 97 0.0015
780 CARDIOMYOPATHY 22 0.0015
781 SKIN HAEMORRHAGE 22 0.0015
782 CHEST DISCOMFORT 152 0.0015
783 HAEMORRHAGE 155 0.0015
784 DELUSION 23 0.0015
785 NASAL CONGESTION 87 0.0015
786 VISUAL IMPAIRMENT 182 0.0015
787 WOUND 41 0.0015
788 SCAR 25 0.0015
789 VERTIGO 89 0.0015
790 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 70 0.0015
791 FEAR 39 0.0014
792 DRUG INEFFECTIVE 1894 0.0014
793 UNRESPONSIVE TO STIMULI 37 0.0014
794 HAEMATOCHEZIA 78 0.0014
795 FALL 469 0.0014
796 MANIA 23 0.0014
797 NEPHROLITHIASIS 64 0.0014
798 VENTRICULAR TACHYCARDIA 23 0.0014
799 PHOTOSENSITIVITY REACTION 23 0.0014
800 RHABDOMYOLYSIS 58 0.0014
801 WEIGHT INCREASED 311 0.0014
802 DISORIENTATION 55 0.0014
803 FATIGUE 1075 0.0014
804 THERAPEUTIC RESPONSE DECREASED 83 0.0014
805 ARTHRALGIA 569 0.0014
806 THERAPY CESSATION 70 0.0014
807 BLOOD PRESSURE ABNORMAL 27 0.0014
808 CEREBROVASCULAR ACCIDENT 225 0.0013
809 BLOOD PRESSURE DECREASED 88 0.0013
810 DYSPEPSIA 130 0.0013
811 HEART RATE INCREASED 130 0.0013
812 AMENORRHOEA 23 0.0013
813 BLOOD GLUCOSE INCREASED 247 0.0013
814 NEUROPATHY PERIPHERAL 123 0.0013
815 ACUTE MYOCARDIAL INFARCTION 38 0.0013
816 CHEST PAIN 238 0.0013
817 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
818 THROAT IRRITATION 57 0.0013
819 INSOMNIA 334 0.0013
820 INFUSION RELATED REACTION 83 0.0013
821 CONFUSIONAL STATE 201 0.0012
822 SPEECH DISORDER 65 0.0012
823 EAR INFECTION 33 0.0012
824 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 88 0.0012
825 PAIN IN JAW 35 0.0012
826 GAIT INABILITY 41 0.0012
827 ANHEDONIA 32 0.0012
828 BLOOD CREATINE PHOSPHOKINASE INCREASED 35 0.0012
829 DYSPHONIA 71 0.0012
830 RASH ERYTHEMATOUS 58 0.0012
831 SEIZURE 139 0.0012
832 EPISTAXIS 90 0.0012
833 PRODUCT DOSE OMISSION IN ERROR 34 0.0012
834 POLLAKIURIA 50 0.0012
835 NEOPLASM MALIGNANT 80 0.0012
836 SPINAL FRACTURE 24 0.0012
837 CARDIAC DISORDER 112 0.0012
838 DIZZINESS 596 0.0012
839 PRESCRIBED OVERDOSE 23 0.0012
840 COLITIS ULCERATIVE 53 0.0012
841 MUSCULOSKELETAL PAIN 62 0.0012
842 PSORIATIC ARTHROPATHY 48 0.0012
843 ARTHRITIS 93 0.0012
844 NO ADVERSE EVENT 213 0.0012
845 RESTLESSNESS 43 0.0012
846 EXPOSURE DURING PREGNANCY 73 0.0012
847 JOINT INJURY 25 0.0012
848 RASH PAPULAR 26 0.0012
849 URINARY INCONTINENCE 34 0.0011
850 LETHARGY 66 0.0011
851 JOINT SWELLING 138 0.0011
852 PRODUCT AVAILABILITY ISSUE 26 0.0011
853 MOBILITY DECREASED 82 0.0011
854 STOMATITIS 69 0.0011
855 GASTRIC DISORDER 39 0.0011
856 ANGIOEDEMA 50 0.0011
857 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
858 WHEEZING 66 0.0011
859 BACK PAIN 258 0.0011
860 FAECES DISCOLOURED 24 0.0011
861 HEAD INJURY 35 0.0011
862 PRODUCT DISPENSING ERROR 24 0.0011
863 LOSS OF CONSCIOUSNESS 139 0.0011
864 PRODUCT DOSE OMISSION ISSUE 318 0.0011
865 HYPOGLYCAEMIA 52 0.0011
866 RIB FRACTURE 22 0.0011
867 NEURALGIA 26 0.0011
868 CHROMATURIA 24 0.0011
869 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
870 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
871 RECTAL HAEMORRHAGE 45 0.0010
872 CARDIAC FAILURE CONGESTIVE 84 0.0010
873 GAIT DISTURBANCE 200 0.0010
874 ILL-DEFINED DISORDER 63 0.0010
875 FREQUENT BOWEL MOVEMENTS 28 0.0010
876 SLEEP DISORDER 73 0.0010
877 DISCOMFORT 63 0.0010
878 DYSSTASIA 30 0.0010
879 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
880 IRRITABLE BOWEL SYNDROME 22 0.0010
881 BLISTER 57 0.0010
882 MEMORY IMPAIRMENT 139 0.0010
883 DYSARTHRIA 38 0.0010
884 MIGRAINE 96 0.0010
885 PRURITUS 386 0.0010
886 AMNESIA 65 0.0010
887 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 180 0.0010
888 LUNG NEOPLASM MALIGNANT 41 0.0010
889 HEART RATE DECREASED 35 0.0010
890 PAIN IN EXTREMITY 293 0.0010
891 OSTEOARTHRITIS 42 0.0010
892 EATING DISORDER 21 0.0010
893 MUSCULOSKELETAL STIFFNESS 85 0.0010
894 CONSTIPATION 211 0.0010
895 HIP FRACTURE 31 0.0010
896 VISUAL ACUITY REDUCED 32 0.0010
897 ALOPECIA 189 0.0010
898 ACCIDENTAL OVERDOSE 35 0.0010
899 FLATULENCE 54 0.0010
900 MENTAL IMPAIRMENT 23 0.0009
901 ANAPHYLACTIC REACTION 52 0.0009
902 ARTHROPATHY 52 0.0009
903 ARRHYTHMIA 43 0.0009
904 PALPITATIONS 106 0.0009
905 FIBROMYALGIA 22 0.0009
906 MOVEMENT DISORDER 29 0.0009
907 PARAESTHESIA 141 0.0009
908 SKIN DISCOLOURATION 41 0.0009
909 MYOCARDIAL INFARCTION 153 0.0009
910 HYPOAESTHESIA 131 0.0009
911 ADVERSE DRUG REACTION 78 0.0009
912 CARDIOVASCULAR DISORDER 22 0.0009
913 DEMENTIA 24 0.0009
914 DRY MOUTH 69 0.0008
915 MENTAL DISORDER 37 0.0008
916 RASH 369 0.0008
917 CONTUSION 81 0.0008
918 NECK PAIN 47 0.0008
919 FEMUR FRACTURE 26 0.0008
920 BLOOD GLUCOSE DECREASED 40 0.0008
921 PAIN 510 0.0008
922 FEELING ABNORMAL 195 0.0008
923 UNDERDOSE 59 0.0008
924 PRODUCT SUBSTITUTION ISSUE 46 0.0008
925 ROAD TRAFFIC ACCIDENT 33 0.0008
926 DEPRESSED MOOD 41 0.0008
927 PANIC ATTACK 28 0.0008
928 FEELING HOT 47 0.0008
929 INCORRECT DOSE ADMINISTERED 175 0.0008
930 HYPERSENSITIVITY 139 0.0007
931 DISTURBANCE IN ATTENTION 40 0.0007
932 INFLUENZA LIKE ILLNESS 61 0.0007
933 RASH PRURITIC 40 0.0007
934 BONE PAIN 43 0.0007
935 COGNITIVE DISORDER 34 0.0007
936 UNEVALUABLE EVENT 55 0.0007
937 FOETAL EXPOSURE DURING PREGNANCY 59 0.0007
938 RHEUMATOID ARTHRITIS 82 0.0007
939 EXPIRED PRODUCT ADMINISTERED 24 0.0007
940 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
941 MUSCLE SPASMS 129 0.0007
942 BURNING SENSATION 49 0.0007
943 INJURY 49 0.0007
944 OVERDOSE 150 0.0007
945 PLASMA CELL MYELOMA 27 0.0007
946 MOOD SWINGS 22 0.0007
947 EYE SWELLING 25 0.0007
948 NERVOUSNESS 35 0.0007
949 HALLUCINATION 50 0.0007
950 BALANCE DISORDER 57 0.0007
951 DEPRESSION 149 0.0007
952 OCULAR HYPERAEMIA 31 0.0007
953 DRY EYE 32 0.0006
954 NEUTROPHIL COUNT DECREASED 26 0.0006
955 RASH MACULAR 22 0.0006
956 DERMATITIS ATOPIC 33 0.0006
957 ERYTHEMA 126 0.0006
958 CONVULSION 34 0.0006
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
960 ANXIETY 166 0.0006
961 HYPERHIDROSIS 74 0.0006
962 URTICARIA 95 0.0006
963 ASTHMA 64 0.0006
964 AGITATION 40 0.0005
965 SUICIDE ATTEMPT 32 0.0005
966 EYE IRRITATION 29 0.0005
967 ACNE 38 0.0005
968 DYSGEUSIA 37 0.0005
969 IRRITABILITY 29 0.0005
970 ECZEMA 25 0.0005
971 ADVERSE EVENT 44 0.0005
972 EMOTIONAL DISTRESS 57 0.0005
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33 0.0005
974 PSORIASIS 59 0.0005
975 SUICIDAL IDEATION 41 0.0004
976 AGGRESSION 22 0.0004
977 HOT FLUSH 32 0.0004
978 DRY SKIN 56 0.0004
979 FLUSHING 41 0.0004
980 SKIN EXFOLIATION 34 0.0004
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
982 INTENTIONAL PRODUCT MISUSE 32 0.0004
983 INJECTION SITE BRUISING 27 0.0003
984 INJECTION SITE HAEMORRHAGE 26 0.0003
985 PRODUCT STORAGE ERROR 27 0.0003
986 DEVICE ISSUE 23 0.0003
987 MALIGNANT NEOPLASM PROGRESSION 26 0.0003
988 BREAST CANCER 23 0.0002
989 DRUG DOSE OMISSION 37 0.0002
990 INJECTION SITE PAIN 66 0.0002
991 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
992 PRODUCT QUALITY ISSUE 23 0.0002